プロモーションスケジュール Lantern Pharma Inc.
詳細なスケジュール
簡易グラフ
会社について Lantern Pharma Inc.
Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. It develops LP-100 for treatment in combination with the class of anticancer agent known as PARP inhibitors. The company also develops LP-300 as a combination therapy for never-smokers with non-small cell lung cancer adenocarcinoma; and LP-284, a novel small molecule and DNA damaging agent for the treatment of mantle cell lymphoma and double hit lymphoma. さらに詳しくIPO date | 2020-06-11 |
---|---|
ISIN | US51654W1018 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Сайт | https://www.lanternpharma.com |
Цена ао | 4.05 |
1日あたりの価格変動: | -1% (3.99) |
---|---|
週ごとの価格変動: | -8.78% (4.33) |
月ごとの料金変更: | -13.19% (4.55) |
3ヶ月間の価格変動: | +23.05% (3.21) |
半年間の価格変動: | +7.92% (3.66) |
年間の価格変動: | -4.82% (4.15) |
3年間の価格推移: | -37.3% (6.3) |
5年間の価格推移: | 0% (3.95) |
10年間の価格推移: | 0% (3.95) |
年初からの価格変動: | +15.16% (3.43) |
|
過小評価
|
効率
|
|||||||||||||||||||||||||||||||||||||
配当金
|
義務
|
成長の衝動
|
機関 | 音量 | 共有, % |
---|---|---|
Vanguard Group Inc | 365334 | 3.4 |
NewEdge Advisors, LLC | 165972 | 1.55 |
Geode Capital Management, LLC | 95036 | 0.88 |
CM Management, LLC | 80000 | 0.74 |
Carlson Capital. L.P. | 60000 | 0.56 |
Commonwealth Equity Services, LLC | 58848 | 0.55 |
Renaissance Technologies, LLC | 43800 | 0.41 |
Redmond Asset Management, LLC | 40662 | 0.38 |
Horizon Kinetics Asset Management LLC | 28791 | 0.27 |
State Street Corporation | 27752 | 0.26 |
ETF | 共有, % | 年間の利益率, % | 配当金, % |
---|---|---|---|
iShares Micro-Cap ETF | 0.00743 | 17.09 | 1.54048 |
Dimensional U.S. Targeted Value ETF | 0.00011 | 26.01 | 1.93487 |
Dimensional U.S. Core Equity 2 ETF | 0.00006 | 30.76 | 1.47098 |
0.00000 | 24.62 | 1.65 |
スーパーバイザー | 役職 | 支払い | 生年 |
---|---|---|---|
Mr. Panna Sharma PH.D. | President, CEO & Director | 684.38k | 1971 (54 年) |
Mr. David R. Margrave | CFO & Secretary | 442.68k | 1961 (64 年) |
Dr. Kishor Gopaldas Bhatia Ph.D. | Chief Scientific Officer & Scientific Consultant | 283.24k | 1955 (70 年) |
Nicole Leber | Investor Relations Associate, Finance & Administrative Coordinator | N/A | |
Dr. Peter L. Nara D.V.M., M.S., Ph.D. | Co-Founder & Advisor | N/A | |
Mr. Ernest Kitt B.S., M.S | Head of Clinical Operations | N/A | |
Dr. Marc C. Chamberlain M.D. | Chief Medical Officer of Starlight Therapeutics |
住所: United States, Dallas. TX, 1920 McKinney Avenue - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.lanternpharma.com
Webサイト: https://www.lanternpharma.com